WHAT YOU NEED TO KNOW: DID YOU KNOW: The Inter Partes Review (IPR) Process is a Low-Cost Alternative to Traditional Patent Litigation and is Regularly Used to Knock Down Erroneously Issued Patents? Bad patents hold up generic and biosimilar drug competition and keep prices high, costing billions every year.  Thankfully, IPR was created as part […]

Continue Reading

WHAT YOU NEED TO KNOW: CAPA Releases Statement on Nomination of Kathi Vidal as Director of the U.S. Patent and Trademark Office (USPTO) “The USPTO will play a significant role in expanding access to affordable life-saving medications for millions of American patients, and CAPA looks forward to working with Kathi Vidal to ensure tackling patent […]

Continue Reading